{"title":"Correction: Effectiveness and safety of weekly paclitaxel and cetuximab as a salvage chemotherapy following immune checkpoint inhibitors for recurrent or metastatic head and neck squamous cell carcinoma: a multicenter clinical study","link":"https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0303720","date":1715263200000,"content":"<p>by Takahiro WakasakiI, Tomomi Manako, Ryuji YasumatsuI, Hirotaka Hara, Satoshi Toh, Muneyuki Masuda, Moriyasu YamauchiID, Yuichiro Kuratomi, Emi Nishimura, Toranoshin Takeuchi, Mioko Matsuo, Rina Jiromaru, Kazuki Hashimoto, Noritaka Komune, Takashi Nakagawa</p>","author":"Takahiro WakasakiI","siteTitle":"PLOS ONE","siteHash":"e9ab556ceb1e4ea76e897a5fa4f394f0bb75c2c2f3d5b0f4766ff77b4a262ac1","entryHash":"3a637763df32b3a00c5707d5f51828111ae6876fc7a25946521ce25b7dbaeb76","category":"Interdisciplinary"}